Nova Patents
AT263771T

Total synthesis of antitumor acylfulvenes

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

26 members in 12 offices

This recordMember, by publication datePriority claim2 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
68946196United States of AmericaA
9713644United States of AmericaW

Members26

Family members, oldest first
DocumentOfficeKind
CA2262648A1CanadaA1
WO9805669A1World Intellectual Property Organization (WIPO)A1
AU3744397AAustraliaA
US5723632AUnited States of AmericaA
US5856580AUnited States of AmericaA
EP0918776A1European Patent Office (EPO)A1
HK1019878A1Hong Kong, ChinaA1
JP2000515552AJapanA
US6160184AUnited States of AmericaA
US6252093B1United States of AmericaB1
US2001029303A1United States of AmericaA1
US6469184B2United States of AmericaB2
US2003050495A1United States of AmericaA1
US6717017B2United States of AmericaB2
EP0918776B1European Patent Office (EPO)B1
AT263771TThis recordAustriaT
ATE263771T1AustriaT1
DE69728544D1GermanyD1
DK0918776T3DenmarkT3
PT918776EPortugalE
EP1454890A2European Patent Office (EPO)A2
DE69728544T2GermanyT2
ES2215234T3SpainT3
EP1454890A8European Patent Office (EPO)A8
EP1454890A3European Patent Office (EPO)A3
JP4267702B2JapanB2